drugset / Trial / NCT03630367
Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the present study was to investigate the efficacy of L-carnitine therapy on the occurrence and prognosis of respiratory distress syndrome
Timeline
- Start
- 2018-10-03
- Primary completion
- 2020-09
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 1 g | Intravenous |
| Background | Dexamethasone | Small molecule | 8 mg | Intramuscular |
Indications
No indication recorded.